Addus HomeCare [ADUS] vs Chemed [CHE] Detailed Stock Comparison
Addus HomeCare
NASDAQ
Loading...
Chemed
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Addus HomeCare wins in 5 metrics, Chemed wins in 14 metrics, with 0 ties. Chemed appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Addus HomeCare | Chemed | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 24.06 | 22.37 | Chemed |
| Price-to-Book Ratio | 1.96 | 5.27 | Addus HomeCare |
| Debt-to-Equity Ratio | 21.75 | 12.15 | Chemed |
| PEG Ratio | 18.93 | 17.49 | Chemed |
| EV/EBITDA | 14.45 | 14.32 | Chemed |
| Profit Margin (TTM) | 6.51% | 11.56% | Chemed |
| Operating Margin (TTM) | 9.41% | 11.00% | Chemed |
| EBITDA Margin (TTM) | 9.41% | 11.00% | Chemed |
| Return on Equity | 8.54% | 24.14% | Chemed |
| Return on Assets (TTM) | 6.59% | 13.56% | Chemed |
| Free Cash Flow (TTM) | $110.38M | $367.97M | Chemed |
| Dividend Yield | N/A | 0.18% | N/A |
| 1-Year Return | -11.59% | -24.95% | Addus HomeCare |
| Price-to-Sales Ratio (TTM) | 1.59 | 2.53 | Addus HomeCare |
| Enterprise Value | $2.13B | $6.22B | Chemed |
| EV/Revenue Ratio | 1.67 | 2.47 | Addus HomeCare |
| Gross Profit Margin (TTM) | 32.59% | 29.85% | Addus HomeCare |
| Revenue per Share (TTM) | $71 | $170 | Chemed |
| Earnings per Share (Diluted) | $4.58 | $19.46 | Chemed |
| Beta (Stock Volatility) | 0.80 | 0.46 | Chemed |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Addus HomeCare vs Chemed Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Addus HomeCare | 1.00% | 4.98% | -1.68% | -0.46% | -5.38% | -11.32% |
| Chemed | 0.10% | 4.18% | -6.56% | -23.50% | -21.37% | -17.54% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Addus HomeCare | -11.59% | 16.71% | 16.33% | 283.94% | 2,274.78% | 1,104.26% |
| Chemed | -24.95% | -11.29% | -14.05% | 191.95% | 759.32% | 974.62% |
Performance & Financial Health Analysis: Addus HomeCare vs Chemed
| Metric | ADUS | CHE |
|---|---|---|
| Market Information | ||
| Market Cap | $2.03B | $6.34B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 239,850 | 233,080 |
| 90 Day Avg. Volume | 172,633 | 205,553 |
| Last Close | $110.19 | $435.33 |
| 52 Week Range | $88.96 - $136.72 | $408.42 - $623.61 |
| % from 52W High | -19.40% | -30.19% |
| All-Time High | $136.72 (Jan 20, 2025) | $654.62 (Mar 11, 2024) |
| % from All-Time High | -19.40% | -33.50% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.22% | 0.04% |
| Quarterly Earnings Growth | 0.22% | -0.26% |
| Financial Health | ||
| Profit Margin (TTM) | 0.07% | 0.12% |
| Operating Margin (TTM) | 0.09% | 0.11% |
| Return on Equity (TTM) | 0.09% | 0.24% |
| Debt to Equity (MRQ) | 21.75 | 12.15 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $56.26 | $82.56 |
| Cash per Share (MRQ) | $5.02 | $17.22 |
| Operating Cash Flow (TTM) | $100.42M | $426.78M |
| Levered Free Cash Flow (TTM) | $50.85M | $285.06M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.18% |
| Last 12-Month Dividend | N/A | $1.00 |
Valuation & Enterprise Metrics Analysis: Addus HomeCare vs Chemed
| Metric | ADUS | CHE |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 24.06 | 22.37 |
| Forward P/E | 18.93 | 17.49 |
| PEG Ratio | 18.93 | 17.49 |
| Price to Sales (TTM) | 1.59 | 2.53 |
| Price to Book (MRQ) | 1.96 | 5.27 |
| Market Capitalization | ||
| Market Capitalization | $2.03B | $6.34B |
| Enterprise Value | $2.13B | $6.22B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.67 | 2.47 |
| Enterprise to EBITDA | 14.45 | 14.32 |
| Risk & Other Metrics | ||
| Beta | 0.80 | 0.46 |
| Book Value per Share (MRQ) | $56.26 | $82.56 |
Financial Statements Comparison: Addus HomeCare vs Chemed
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ADUS | CHE |
|---|---|---|
| Revenue/Sales | $349.44M | $646.94M |
| Cost of Goods Sold | $235.57M | $430.53M |
| Gross Profit | $113.88M | $216.41M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $32.89M | $94.76M |
| EBITDA | $37.38M | $112.02M |
| Pre-Tax Income | $29.95M | $95.67M |
| Income Tax | $7.89M | $23.92M |
| Net Income (Profit) | $22.05M | $71.76M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ADUS | CHE |
|---|---|---|
| Cash & Equivalents | $96.95M | $173.88M |
| Total Current Assets | $257.83M | $502.39M |
| Total Current Liabilities | $147.94M | $290.56M |
| Long-Term Debt | $238.15M | $102.08M |
| Total Shareholders Equity | $995.38M | $1.18B |
| Retained Earnings | $397.66M | $2.79B |
| Property, Plant & Equipment | $69.77M | $724.13M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ADUS | CHE |
|---|---|---|
| Operating Cash Flow | $16.26M | $34.75M |
| Capital Expenditures | $-1.88M | $112,000 |
| Free Cash Flow | $17.07M | $19.46M |
| Debt Repayment | $-20.00M | N/A |
| Common Stock Repurchase | N/A | $-33.22M |
Short Interest & Institutional Ownership Analysis
| Metric | ADUS | CHE |
|---|---|---|
| Shares Short | 678,415 | 388,345 |
| Short Ratio | 4.45 | 1.95 |
| Short % of Float | 0.05% | 0.03% |
| Average Daily Volume (10 Day) | 239,850 | 233,080 |
| Average Daily Volume (90 Day) | 172,633 | 205,553 |
| Shares Outstanding | 18.15M | 14.56M |
| Float Shares | 17.32M | 14.28M |
| % Held by Insiders | 0.03% | 0.02% |
| % Held by Institutions | 1.03% | 0.98% |
Dividend Analysis & Yield Comparison: Addus HomeCare vs Chemed
| Metric | ADUS | CHE |
|---|---|---|
| Last 12-Month Dividend | N/A | $1.00 |
| Last 12-Month Dividend Yield | N/A | 0.18% |
| 3-Year Avg Annual Dividend | N/A | $1.37 |
| 3-Year Avg Dividend Yield | N/A | 0.08% |
| 3-Year Total Dividends | N/A | $4.10 |
| Ex-Dividend Date | N/A | Nov 18, 2024 |